January 26th Lunch & Learn Event on Sjogren’s Syndrome PDF Print E-mail
Thursday, 07 January 2010 12:16
For those of you in the state of Texas, Northwest Rheumatology, a division of Northwest Diagnostic Clinic, will host a free Lunch & Learn event on Sjogren’s Sydrome: The Forgotten Disease on Tuesday, Jan. 26, from 11:45 a.m. – 1 p.m. at the South Montgomery County Woodlands Chamber of Commerce Board Room.

Dr. Tamar Brionez of Northwest Rheumatology will speak on the definition, symptoms and therapeutics of Sjogren’s Syndrome, a disease often undiagnosed or misdiagnosed due to symptoms that mimic other medical conditions. This Lunch & Learn is the second in a quarterly series that will address a variety of health topics.

“This is a great topic to discuss,” said Dr. Brionez. “The lunch will be very informative and I look forward to addressing the questions and concerns commonly associated with Sjogren’s Syndrome. I am excited to be the next speaker in this series.”

The event is free and open to the public. Reservations are required and must be made by Friday, Jan. 22.

With four physicians on staff, Northwest Rheumatology specializes in the treatment of Rheumatoid Arthritis, Scleroderma, Sjogren’s Syndrome, Psoriatic Arthritis, Lupus and other autoimmune diseases, as well as Osteoporosis and Osteoarthritis. With offices in The Woodlands and Houston, the clinic offers several areas of expertise including family practice, internal medicine and rheumatology, as well as on-site ancillary services such as CT, MRI, nuclear medicine, ultrasound, bone density testing, infusion and laboratory services.

For more information, do click here.
 
More articles :

» The Impact Of Art On Wellbeing In Autoimmune Disease

An innovative Newcastle research project is measuring the impact of creating art on the symptoms and overall wellbeing of people living with an autoimmune illness.A team at the University of Newcastle, in conjunction with the at John Hunter...

» Pressure and Pain In Systemic Sclerosis/ Scleroderma

Begonya Alcacer-Pitarch, Maya H Buch, Janine Gray, Christopher P Denton, Ariane Herrick, Nuria Navarro-Coy, Howard Collier, Lorraine Loughrey, Sue Pavitt, Heidi J Siddle, Jonathan Wright, Philip S Helliwell, Paul Emery, Anthony C RedmondStudy...

» Study Indicates Scleroderma Mortality Rates Being Underestimated

patients have a significantly reduced life expectancy that is most likely being underestimated, delegates have heard. Most studies on scleroderma survival are based on prevalent cohorts, where no limit is placed on disease duration at the time of...

» Egr-1: A Target for Scleroderma Therapy

Two separate research groups funded by the (NIAMS) have discovered that the molecule EGR-1 (early growth response 1), which regulates gene expression, plays a central role in the development of fibrosis, a condition in which organ-supporting tissue...

» Scleroderma Research Foundation To Host Patient Webinar Series

The announced the first in a series of free informational Webinars for people living with and others directly or indirectly affected by the disease. The first Webinar will highlight new clinical trials and results from recent studies.The 2011/2012...

» Geneticists Hunt for Scleroderma Triggers

In all its forms, gives Dartmouth geneticist Michael Whitfield, his graduate students, and his postdoctoral researchers a sense of urgency in their search for the triggers of the chronic condition. In a study that the Journal of Investigative...